This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jul;157(1):172.

doi: 10.1016/j.jpeds.2010.05.010.

Metformin treatment for adolescent obesity has limited long-term benefits

Min Hae Park¹, Sanjay Kinra

Affiliations

PMID: 20547271
DOI: 10.1016/j.jpeds.2010.05.010

Comment

Metformin treatment for adolescent obesity has limited long-term benefits

Min Hae Park et al. J Pediatr. 2010 Jul.

. 2010 Jul;157(1):172.

doi: 10.1016/j.jpeds.2010.05.010.

Authors

Min Hae Park¹, Sanjay Kinra

Affiliation

¹ London School of Hygiene and Tropical Medicine, London, United Kingdom.

PMID: 20547271
DOI: 10.1016/j.jpeds.2010.05.010

No abstract available

PubMed Disclaimer

Comment on

Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up.
Wilson DM, Abrams SH, Aye T, Lee PD, Lenders C, Lustig RH, Osganian SV, Feldman HA; Glaser Pediatric Research Network Obesity Study Group. Wilson DM, et al. Arch Pediatr Adolesc Med. 2010 Feb;164(2):116-23. doi: 10.1001/archpediatrics.2009.264. Arch Pediatr Adolesc Med. 2010. PMID: 20124139 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources